Health Risks: Efficacy Loss, Contamination, and Consistency Using expired compounded semaglutide poses three primary risks: reduced therapeutic efficacy (weakened weight-loss or glycemic benefits), increased contamination risk (bacterial growth or chemical byproducts), and dosing inconsistency (unmeasurable potency)
If a person has too little GLP-1, this may lead to a person eating more during meals or snacking between meals
Quickobook Call to Action If youre considering GLP-1 therapy for diabetes, obesity, or inflammation control , talk to an expert
Patients with a history of kidney disease, acute kidney injury, or chronic kidney disease should consult a healthcare professional to assess risks
The pharmacological mechanism is identical the underlying molecule is the same but compounded-product-specific dosing, vehicle, and formulation can vary by pharmacy
Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation